Macular Degeneration

Age is the biggest risk factor for macular degeneration. The condition is rare before age 55, but your risk doubles about every 10 years after age 55. By age 75, about 13 percent of people have some form of AMD.

If you have a parent, sibling, or child with macular degeneration, your risk is much higher. Researchers have found several genes that increase AMD risk, and genetic testing may help predict your likelihood of developing the condition.

Smoking is the most important controllable risk factor for AMD. It reduces oxygen flow to your eyes and doubles your risk of developing the condition. The good news is that quitting smoking can reduce this risk over time.

Uncontrolled high blood pressure can damage the small blood vessels in your eyes. People with high blood pressure are more likely to develop wet AMD and may have faster progression of the disease.

Being overweight increases your risk of developing advanced macular degeneration. A diet high in saturated fats and low in antioxidants may also contribute to AMD development and progression.

Long-term exposure to bright sunlight without proper eye protection may increase your risk of macular degeneration. The blue and ultraviolet light from the sun can damage retinal cells over many years.

Macular degeneration is more common in Caucasians than in African Americans or Hispanics. Women may be at slightly higher risk than men, possibly because they tend to live longer.

Having heart disease, high cholesterol, or diabetes may increase your risk of macular degeneration. These conditions can affect blood flow to your eyes and contribute to retinal damage.

For people with intermediate or advanced dry AMD, special vitamin supplements can slow disease progression by about 25 percent. These supplements contain vitamin C, vitamin E, zinc, copper, lutein, and zeaxanthin in specific amounts proven effective in clinical studies.

These medications are injected directly into the eye to stop abnormal blood vessel growth and reduce fluid leakage. Common medications include Lucentis, Eylea, and Avastin. Most people need injections every 4 to 8 weeks initially, then less frequently as the condition stabilizes.

In some cases of wet AMD, laser treatment can seal leaking blood vessels. However, this treatment is less commonly used now because anti-VEGF injections are usually more effective and cause less damage to surrounding tissue.

This treatment combines a light-activated drug with laser therapy to destroy abnormal blood vessels. It is sometimes used for specific types of wet AMD, particularly when the abnormal vessels are not directly under the center of the macula.

Recent FDA approvals include treatments for geographic atrophy, the advanced form of dry AMD. These include Syfovre and Izervay, which can slow the progression of retinal cell death in some patients.

When medical treatments cannot restore vision, low vision specialists can help you make the most of your remaining sight through training, adaptive techniques, and assistive devices.

Currently, there is no cure that can reverse damage already caused by macular degeneration. However, treatments can slow progression, prevent further vision loss, and sometimes improve vision, especially for wet AMD.

Macular degeneration rarely causes complete blindness because it typically affects only central vision while leaving peripheral vision intact. Most people retain enough side vision to move around safely and maintain some independence.

Dry AMD usually progresses slowly over many years, while wet AMD can cause rapid vision loss within weeks or months. The progression rate varies greatly between individuals, which is why regular monitoring is important.

AREDS2 supplements are recommended specifically for people with intermediate or advanced dry AMD in one or both eyes. These supplements are not helpful for early-stage AMD or for preventing the condition in healthy eyes.

Initially, most people with wet AMD need injections every 4 to 8 weeks. As the condition stabilizes, the time between injections may be extended. Some people need ongoing injections indefinitely to maintain vision stability.

The injections are performed with numbing drops and usually cause only mild discomfort. Most people describe feeling pressure rather than pain. Any discomfort typically lasts only a few seconds during the actual injection.

This depends on how much your vision is affected and your local driving requirements. Some people with early-stage AMD can continue driving safely, while others may need to limit driving to familiar routes or stop driving altogether.

Genetics play a significant role in AMD risk. Having a close family member with the condition increases your risk substantially. However, having the genetic risk factors does not guarantee you will develop the disease.

While a healthy diet rich in antioxidants and omega-3 fatty acids can reduce your risk, it works best when combined with other healthy lifestyle choices like not smoking, exercising regularly, and protecting your eyes from UV light.

Cataracts cause clouding of the lens in your eye and typically cause overall blurry vision that can be corrected with surgery. Macular degeneration affects the retina and causes central vision problems that cannot be corrected with glasses or cataract surgery.

Yes, many people with macular degeneration continue using digital devices with helpful modifications like larger text, high contrast settings, screen reading software, or voice commands. Your eye doctor or low vision specialist can suggest specific adaptations.

Yes, regular self-monitoring with an Amsler grid can help detect changes in your vision between doctor visits. Test each eye separately daily, and contact your eye doctor immediately if you notice new distortions or blind spots.

While stress does not directly cause macular degeneration, chronic stress can contribute to other health problems like high blood pressure that may worsen the condition. Managing stress through relaxation techniques, exercise, and social support is beneficial for overall health.

Yes, researchers are constantly studying new treatments for both dry and wet AMD. Ask your eye doctor about clinical trials that might be appropriate for your specific situation, or search for trials at clinicaltrials.gov.

Your eye doctor can refer you to low vision specialists, or you can contact organizations like the American Foundation for the Blind, National Federation of the Blind, or your state's department of services for the blind for local resources.